Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | UBE2L6 |
| Upstream (Parents) |
|---|
| (<<) MS4A6A → UBE2L6 |
| (<<) TRIM22 → UBE2L6 |
| (<<) GBP1 → UBE2L6 |
| (<<) BTN3A3 → UBE2L6 |
| (<<) IFIT3 → UBE2L6 |
| Downstream (Children) |
|---|
| UBE2L6 → MYL7 (>>) |
| UBE2L6 → PSMB9 (>>) |
| UBE2L6 → KYNU (>>) |
| UBE2L6 → LAG3 (>>) |
| UBE2L6 → RARRES3 (>>) |
| UBE2L6 → BST2 (>>) |
| UBE2L6 → IFNG (>>) |
| UBE2L6 → HERC5 (>>) |
| UBE2L6 → CAND2 (>>) |
| UBE2L6 → USP18 (>>) |
| UBE2L6 → CASP1 (>>) |
| UBE2L6 → RTP4 (>>) |
| UBE2L6 → XAF1 (>>) |
| UBE2L6 → BTN3A3 (>>) |
| UBE2L6 → STAT1 (>>) |
| UBE2L6 → IL15 (>>) |
| UBE2L6 → MYCL1 (>>) |
| UBE2L6 → IFIT3 (>>) |
